红酒及其成分对神经认知障碍的潜在影响:叙述性审查
Virginia Boccardi1, Luca Tagliafico2,3, Angelica Persia2
1Division of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, 06123 Perugia, Italy.
Nutrients
|October 26, 2024
概括
在临床前研究中,红葡萄酒中的多可以有望预防认知能力下降. 然而,目前的证据不足以推红酒用于预防酒精风险导致的神经认知障碍.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 营养科学 营养科学
背景情况:
- 老龄化人口面临慢性退行性疾病,特别是神经认知障碍的增长率.
- 对这些疾病的预防策略至关重要.
- 红葡萄酒及其化合物对神经疾病有潜在的益处.
研究的目的:
- 审查目前有关红葡萄酒对神经认知障碍影响的证据.
- 检查临床前和临床研究的发现.
主要方法:
- 现有科学文献的叙述性审查.
- 对临床前模型和人类临床试验的分析.
主要成果:
- 临床前研究表明,红葡萄酒中的多可以预防痴呆症.
- 临床证据对于酒精对大脑健康的风险益处是不确定的.
结论:
- 没有足够的证据支持红葡萄酒消费用于预防由于健康风险而导致的神经认知障碍.
- 红葡萄酒中的多值得进一步研究神经保护潜力.
相关概念视频
CNS Depressants: Alcohol and Nicotine
177
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
177
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
101
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
101
Role of Neurotransmitters in Memory
456
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
456
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K
Local Anesthetics: Adverse Effects
392
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
392
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


